Rapid Developments to Enhance Patient Experience in GU Cancer
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
The Dawn of AI in Prostate Cancer Care
A powerful new ally is emerging in cancer care: artificial intelligence.
